rs62514950
Variant summary
Our verdict is Pathogenic. Variant got 8 ACMG points: 8P and 0B. PP3PM3PP4_ModeratePM2PS3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.809G>A (p.Arg270Lys) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded). (PMID:21871829, 23856132). This variant has an extremely low allele frequency (MAF=0.00016) in gnomAD. This variant has 11% residual PAH activity (PMID:27620137). This variant was detected with multiple pathogenic variants: IVS10nt-11G>A (2 patients), L348V, S349P, R158Q, E390G, D415N (PMID:21871829); and IVS4+5G>T (PMID:23856132). Computational prediction tools and conservation analysis support a deleterious effect. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very-strong, PM2, PP4_Moderate, PP3, PS3_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA229781/MONDO:0009861/006
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.809G>A | p.Arg270Lys | missense_variant | 7/13 | ENST00000553106.6 | NP_000268.1 | |
PAH | NM_001354304.2 | c.809G>A | p.Arg270Lys | missense_variant | 8/14 | NP_001341233.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106.6 | c.809G>A | p.Arg270Lys | missense_variant | 7/13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
PAH | ENST00000307000.7 | c.794G>A | p.Arg265Lys | missense_variant | 8/14 | 5 | ENSP00000303500.2 | |||
PAH | ENST00000549247.6 | n.568G>A | non_coding_transcript_exon_variant | 1/6 | 2 | |||||
PAH | ENST00000635477.1 | c.-32G>A | upstream_gene_variant | 5 | ENSP00000489230.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251348Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135826
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727224
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 03, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PAH function (PMID: 16545551, 17935162, 25453233, 27620137). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function. ClinVar contains an entry for this variant (Variation ID: 102846). This missense change has been observed in individual(s) with phenylketonuria and hyperphenylalaninemia (PMID: 12173030, 20082265, 20187763, 23500595, 23856132). This variant is present in population databases (rs62514950, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 270 of the PAH protein (p.Arg270Lys). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 05, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 26, 2024 | - - |
Pathogenic, reviewed by expert panel | curation | ClinGen PAH Variant Curation Expert Panel | Jun 08, 2020 | The c.809G>A (p.Arg270Lys) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded). (PMID: 21871829, 23856132). This variant has an extremely low allele frequency (MAF=0.00016) in gnomAD. This variant has 11% residual PAH activity (PMID: 27620137). This variant was detected with multiple pathogenic variants: IVS10nt-11G>A (2 patients), L348V, S349P, R158Q, E390G, D415N (PMID: 21871829); and IVS4+5G>T (PMID: 23856132). Computational prediction tools and conservation analysis support a deleterious effect. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very-strong, PM2, PP4_Moderate, PP3, PS3_supporting. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 06, 2020 | - - |
not provided Pathogenic:4Other:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8528673, 11180595, 20082265, 20187763, 23856132, 29749107, 34828281, 17935162, 25750018, 27620137, 9598724, 7914195, 12173030, 16545551, 25453233, 23500595, 21871829, 26666653, 31355225, 32778825, 33465300) - |
not provided, no classification provided | literature only | DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 15, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 25, 2022 | The variant has been reported in multiple individuals largely affected with classic PKU when another severe disease-causing variant is present on the other allele (PMID: 20082265 (2010), 21871829 (2011), 23856132 (2013), 26666653 (2015), 33465300 (2021)). Functional studies have shown that this variant causes severely reduced activity ranging from 2.1 to 11% of the wild-type activity (PMID: 16545551 (2006), 27620137 (2016)). Based on the available information, this variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at